Ronald Cohen,MD- Appointed Chief, Section of Endocrinology, Diabetes & Metabolism

October 01, 2015

Ronald Cohen,MD

Ronald Cohen, MD, Associate Professor of Medicine,  has been  named as the new chief of the Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism (EDM)  effective October 1, 2015. For the past 15+ months, Dr. Cohen has served the Department of Medicine and the Section in an interim capacity where he has demonstrated outstanding leadership and thoughtful academic vision.   Dr. Cohen has served on the faculty of the Department of Medicine for 15 years and his appointment reflects his many years of hard work and dedication.   He received his MD from Cornell University in 1992 where he was selected to the Alpha Omega Alpha Medical Honor Society, and was a recipient of the NIDDK Medical Student Award for Excellence and the AFCR Medical Student Award.  Dr. Cohen then completed his internal medicine residency and endocrinology fellowship training at Beth Israel Hospital, followed by a two year instructorship appointment at Harvard Medical School. In 2000 he was recruited to our EDM section as an assistant professor.  In 2007 he was promoted to the rank of associate professor. 

Within the University of Chicago community Dr. Cohen has served on various faculty committees and has been recognized for his outstanding teaching and mentorship skills. In 2010 he was recipient of the  Llewellyn John and Harriet Manchester Quantrell Award for Excellence in Undergraduate Education where he created, along with Matthew Brady and other DOM faculty, a three course menu of endocrinology courses , spanning cell signaling to physiology and pathophysiology.     With his enthusiasm for wanting to teach students “to understand the important job that hormones play in the human body”, enrollment in the course increased 5 fold.     As a medical educator, he serves as a co-track leader in the Basic Science Track for Scholarship and Discovery and as a member of the PSOM Summer Research Program (SRP) Steering Committee and Fellowship Review Committee. He has mentored nearly a dozen trainees.   

As a researcher, Dr. Cohen’s investigates the relationship between diabetes and adipose tissue, where he is working to develop novel therapies for the treatment of obesity and type 2 diabetes. He has developed mouse models to investigate the roles that a nuclear protein called SMRT (NCoR2) plays in metabolism and insulin sensitivity.  His research has been supported by the NIH and the  American Diabetes Association.  He also serves as a co-investigator on a project funded by the Susan G. Komen for a Cure Foundation targeting stress receptor biology and an NIH R01 focused on circadian genes and adipose function.  His scholarly work has resulted in over four dozen published papers  and book chapters.

As a clinician, Dr. Cohen specializes in specializes in the diagnosis and management of thyroid diseases with a particular focus on thyroid cancer. He also has a clinical interest in diabetes, obesity and metabolic disorders.

Nationally, Dr. Cohen serves as a standing member of the National Institutes of Health Molecular and Cellular Endocrinology Study Section, and serves on the editorial board for the Journal of Biological Chemistry and Frontiers in Pituitary Endocrinology.   He is an active member of the Endocrine Society, American Thyroid Association and the American Diabetes Association where he has served as chair for a variety of symposia and on various research committees.